Pay in 4 interest-free payments of $34.75 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Overall response rate is 35% including 12 CRs
ATB-346 may therefore be an attractive agent for chemoprevention of colon cancer
SCH 51344 inhibits ras transformation by a novel mechanism
33(2):300-9
(2011) 53rd ASH Annual Meeting and Exposition
IDH-C227 - IDH1 Inhibitor. CAS# 1355324-14-9 0232 Overall response rate is 35%IDH C227, CAS No. 1355324 14 9, is a potent and selective IDH1 R132H inhibitor first reported in patent WO2012009678. It can inhibit the enzymatic activity of IDH1 R132H in vitro with an IC50 < 0. 1 M, and 2 HG production in HT1080 and U87MG cells with IC50 < 0. 25 M. Because the mutated form of IDH1 produces the metabolite, 2 hydroxyglutarate (2HG), which may contribute to the formation and malignant progression of gliomas as well as other forms of
US$ 29.99
US$ 24.99
US$ 598.98